Intrommune Therapeutics

View the org chart displaying its 11 main executives

Most searched biographies at Intrommune Therapeutics

• Michael Nelson, Chief Executive Officer
• Jonathan Rich, Director
• Hem Pandya, Director

Popular executive movements at Intrommune Therapeutics

• Jonathan Rich has joined the company as Director  (posted on March 13 2024).
• Hem Pandya has joined the company as Director  (posted on March 13 2024).

Create your alert
to follow the executive moves at Intrommune Therapeutics.

Intrommune Therapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Intrommune Therapeutics

• Intrommune Therapeutics Completes Last Patient Last Visit in the Phase 1 OMEGA Study for Peanut Allergy
• Intrommune Therapeutics Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy
• Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy
• Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory
• Intrommune Expands and Strengthens Senior Leadership Team

Social media about Intrommune Therapeutics

• Intrommune Therapeutics on Wikipedia, Google News & Yahoo Finance
• Intrommune Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Michael Nelson

Call Intrommune Therapeutics at +1 844...

View the org chart

Register to receive your alert

Report an error